Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Risk Reduction Behavior 1Prostatic Neoplasms 1Hot Flashes 1Focus of Study is Healthy Women at Risk for Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Acupuncture Therapy 10Gabapentin 7Venlafaxine Hydrochloride 5Isoflavones 3Bupivacaine 3black cohosh root extract 2Tamoxifen 2Soybean Proteins 2Sodium Chloride 2Magnesium Oxide 2Control Groups 2Citalopram 2oxybutynin 1liposomal amphotericin B 1fezolinetant 1bazedoxifene 1Zolpidem 1Vitamin B 6 1Therapeutics 1Testosterone 1Tablets 1Sugars 1Solifenacin Succinate 1Sertraline 1Pregabalin 1Mindfulness-Based Stress Reduction 1Mindfulness 1Mind-Body Therapies 1Linseed Oil 1Hypnosis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hot Flashes × Estrogens, Conjugated (USP) × Clear all
NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡